1.Discussion on Exploitation of Private Brand Products in Pharmaceutical Retail Enterprises
China Pharmacy 2005;0(22):-
OBJECTIVE:To discuss the necessity,feasibility and methods for exploitation of private brand products in pharmaceutical retail enterprises.METHODS:Recent data and materials about the pharmaceutical retail industry were referred to,the background for the rise of private brands in pharmaceutical retail industry,the advantages of private brand,and the current exploiting situation of private brand products in domestic pharmaceutical retail enterprises were analyzed.RESULT &CONCLUSION:With the considerable scale,distributing net,marketing,brand management and desirable reputation,pharmaceutical retail enterprises can choose appropriate products,methods and brand positioning to exploit private brand products.
2.Discussing Brand Strategies of Pharmaceutical Manufacture Enterprises from Enterprise Brands and Product Brands
China Pharmacy 1991;0(01):-
OBJECTIVE:To provide references for drug manufacturing enterprises in dealing with the relationship be-tween enterprise brand and product brand.METHODS:The study of the relationship between enterprise brand and product brand was performed and the brand strategies of drug manufacturing enterprises were analyzed from aspects of enterprise brand and product brand.RESULTS&CONCLUSION:Brand strategies should be varied with different degrees of closeness of relationship between enterprise brand and product brand,drug enterprises should take different measures to exert the advan-tages of brand strategy while avoiding its disadvantages.
3.Influence of Regulation on the Stock Trade between Retailers and Suppliers on Drug Retailing
China Pharmacy 1991;0(05):-
OBJECTIVE:To discuss the possible influence of the Regulation on the Stock Trade between Retailers and Suppliers(which was called in the following as “Regulation” for short) on drug retailing for the reference of drug retailers and suppliers.METHODS:The origin and the status quo of “Regulation” were studied and the influence of which on drug retailing was analyzed.RESULTS & CONCLUSION:Drug retailing was considerably influenced by policy factor,this issue of “Regula_tion” may change some unfair business behaviors such as delaying in payment and charging unreasonable entrance fee,and influences the strength contrast between drug retailers and suppliers.
4.Opportunities and Challenges for the Expanding of Traditional Chinese Medicine in European Union Herbal Drug Market
China Pharmacy 2001;0(07):-
OBJECTIVE:To facilitate a better understanding of the European Union(EU)herbal drugs market for Chinese TCM enterprises and to promote the internationalization of Chinese traditional medicines.METHODS:The opportunities and challenges confronted by TCM enterprises in their expanding of their products in the EU herbal medicine market were analyzed based on the knowledge about market size,market segmentation,consumption patters and developmental tendencies of the EU herbal medicine market.RESULTS&CONCLUSIONS:There were both opportunities and challenges for the expanding of traditional Chinese medicines in the EU herbal medicine market,yet on the whole,the opportunities were more than the challenge.Chinese enterprises should strive to further expand the EU herbal medicine market.
5.Governmental Price-Cutting Policy and Expelling of Low Price Drugs from Market by High Price Drugs
China Pharmacy 2001;0(10):-
OBJECTIVE:To put forward proposals for governments on how to properly regulate drug market.METHODS:The theory of price elasticity in economics was applied for the analysis.RESULTS & CONCLUSIONS:With the increasing of national income year by year,the cases for high price drugs to expel low price drugs has become increasingly common.The government policies should be based on the development of pharmaceutical industry,meanwhile government should take mild policy to ease the contradictions arose from the development.
6.Brief Introduction on the Disclosure of FDA Information in US and Its Implication
China Pharmacy 2005;0(22):-
OBJECTIVE:To provide reference for food & drug regulatory authorities in China to disclose government information.METHODS:In the light of the development and status quo of the disclosure of information in US FDA,the access,content and procedure for the disclosure of information in FDA were discussed.RESULTS & CONCLUSIONS:There are many similarities between US and China in the disclosure of information.In view of the practical situation of governmental information disclosure in food and drug regulatory authorities in China,Chinese government should be able to find out such key issues as the human and financial support is much needed in FDA information disclosure,the disclosure level should be in line with our national condition,a three-dimensional publicity system of government information at different level should be established and emphasis should be laid to the key disclosed information etc based on the research on the development,access,content and procedure of information disclosure in FDA.
7.Analysis of the effect of metabolic parameters on the self-efficacy in patients with diabetes mellitus
Chinese Journal of Practical Nursing 2013;(11):19-22
Objective To investigate the effect of metabolic parameters on the self-efficacy in patients with diabetes mellitus.Methods 175 diabetes mellitus patients were recruited by random sampling method.Demographic data and metabolic parameters were obtained and the scales of self-efficacy of diabetes patients were evaluated by secd6.We further analyzed the effect of metabolic parameters on the selfeffficacy in diabetes mellitus patients.Results Two-hour postprandial blood glucose had negative correlation with self-efficacy among 10 metabolic parameters in diabetes mellitus patients.Conclusions Twohour post-prandial hyperglycemia affects the scale of self-effcacy.So we should strengthen the management of two-hour postprandial hyperglycemia to increase the self-efficacy in diabetes mellitus patients.
8.Determinants on aged population’s health expenditures in China
Chinese Journal of Health Policy 2015;(7):68-73
Objective:To provide references for policy-making on the establishment of a sound healthcare sys-tem for China’s aged population. Methods:Based on the framework of The Behavioral Model of Health Services Use and data from China Health and Retirement Longitudinal Study in 2011 , the Tobit model of aged population’s health expenditures is built. Results: Self-rated health conditions, chronic disease, medical insurance, endowment insur-ance, self-rated living standard, age, gender, marital status and urban-rural character are the significant determi-nants. Conclusions:The healthcare system for China’s aged population should be built through simultaneously apply-ing disease prevention and access facilitation policies and the characteristic differences of different groups of aged pop-ulation should be taken into consideration.
9.Study on the Selection of Technology Innovation Mode of Pharmaceutical Industry in China Based on En-tropy Method
China Pharmacy 2015;(28):3889-3891,3892
OBJECTIVE:To evaluate technology innovation capability of pharmaceutical industry in 30 provinces(regions and cities)and explore suitable innovation mode for each type. METHODS:The entropy method was adopted to establish comprehen-sive evaluation mode of technology innovation capability of pharmaceutical industry. The mode was used to measure comprehensive score and ranking of pharmaceutical industry in 30 provinces(regions and cities). Those 30 provinces(regions and cities)were di-vided into 3 types,including high technology innovation ability (type Ⅰ),medium technology innovation ability (type Ⅱ) and low technology innovation ability (type Ⅲ),and relevant suggestions on innovation mode were put forward. RESULTS & CON-CLUSIONS:According to the establishment of evaluation index system that included innovation resources input capability,innova-tion output capability,innovation potentiality and innovation environment,significant differences were found among these regions in technology innovation capability. For those 8 provinces (regions and cities) with high technology innovation ability,such as Shandong,Jiangsu and so on,which belongs to the type Ⅰ,local pharmaceutical enterprises should adopt the innovation mode of independent innovation dominant,cooperative innovation as a supplement;for those 9 provinces(regions and cities)with medium technology innovation ability,such as Hebei,Sichuan and so on,which belongs to the type Ⅱ,local pharmaceutical enterprises should select the mode of cooperative innovation of the combination of production,teaching and research;for those 13 provinces (regions and cities) with low technology innovation ability,such as Hainan,Ningxia,which belongs to the type Ⅲ,should the mode of giving priority to imitation innovation and cooperative innovation as a supplement.
10.Discussion on the Strategy of Chain Drugstores in Replying to Drug Price War
China Pharmacy 1991;0(06):-
OBJECTIVE:To provide the ideas about how the chain drugstores to reply to drug price war.METHODS:Economically,the competition between drugstore was discussed and the respective advantages and disadvantages of fair-price and chain drugstores were analysed.RESULTS &CONCLUSION:Chain drugstores should improve their pharmaceutical service,base oneself upon market voids,and exert self-advantages,if they want to win in price war.